Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (9)

2024

  1. Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 24

  2. Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons

    Pharmaceuticals, Vol. 17, Núm. 3

  3. Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound

    Pharmaceuticals, Vol. 17, Núm. 5

  4. Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids

    Plants, Vol. 13, Núm. 3

2023

  1. In vitro activity and mechanism of cell death induction of cyanomethyl vinyl ethers derivatives against Trypanosoma cruzi

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 22, pp. 72-80

  2. Laurequinone, a Lead Compound against Leishmania

    Marine Drugs, Vol. 21, Núm. 6

  3. Withaferin A-silyl ether analogs as potential anti-kinetoplastid agents targeting the programmed cell death

    Biomedicine and Pharmacotherapy, Vol. 157

2022

  1. Inhibition of Acanthamoeba polyphaga by chlorhexidine-mediated oxidative stress response

    Journal of Global Antimicrobial Resistance, Vol. 30, pp. 468-473

  2. Pitavastatin loaded nanoparticles: A suitable ophthalmic treatment for Acanthamoeba Keratitis inducing cell death and autophagy in Acanthamoeba polyphaga

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 180, pp. 11-22